Abla M Sibai1, Rania A Tohme2, Mohamad M Almedawar3, Taha Itani4, Sara I Yassine1, Eden A Nohra5, Hussain A Isma'eel6. 1. Department of Epidemiology & Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon. 2. Department of Epidemiology & Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon; Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. 3. Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Vascular Medicine Program, American University of Beirut Medical Center, Beirut, Lebanon. 4. Department of Public Health Medicine, School of Public Health, University of Bielefeld, Bielefeld, Germany. 5. Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon. 6. Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Vascular Medicine Program, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: hi09@aub.edu.lb.
Abstract
OBJECTIVE: Globally, waterpipe (WP) smoking is becoming a more prevalent form of tobacco consumption. Whilst research so far has demonstrated a significant link between WP use and a number of health outcomes, little is known of its association with heart disease. We examine in this study the association of WP smoking with angiographically confirmed coronary artery disease (CAD). METHODS: A total of 1210 patients, aged 40 years and over and free from smoking-associated illnesses or history of cardiovascular procedures, admitted for coronary angiography at four major hospitals in Lebanon, were included. The extent of CAD was summarized in two ways, firstly as diseased (≥ 50% and ≥ 70% occlusion in at least one main coronary artery) versus non-diseased (entirely normal coronaries), and secondly, as CAD cumulative score based on Duke CAD Prognostic Index. A score of WP-years, capturing intensity and lifetime duration of exposure, was estimated for each individual. RESULTS: Lifetime exposure exceeding 40 WP-years was associated with a threefold significant increase in the odds of having severe stenosis (≥ 70%) compared to non-smokers (OR = 2.94, 95% CI 1.04-8.33) as well as with the CAD Index (β = 7.835, p-value = 0.027), net of the effect of socio-demographic characteristics, health behaviors and co-morbidity. A dose-response relationship between WP-years and percent stenosis was also established. WP smoking status (never, past and current) did not associate with CAD. CONCLUSIONS: Cumulative exposure to WP smoking is significantly associated with severe CAD. There is a need to monitor WP use among cardiac patients and include this information in their medical charts in the same manner cigarettes smoking is documented. This is likely to increase awareness of the hazards of WP smoking and prompt physicians to target WP tobacco control by providing advice to their patients on WP smoking cessation.
OBJECTIVE: Globally, waterpipe (WP) smoking is becoming a more prevalent form of tobacco consumption. Whilst research so far has demonstrated a significant link between WP use and a number of health outcomes, little is known of its association with heart disease. We examine in this study the association of WP smoking with angiographically confirmed coronary artery disease (CAD). METHODS: A total of 1210 patients, aged 40 years and over and free from smoking-associated illnesses or history of cardiovascular procedures, admitted for coronary angiography at four major hospitals in Lebanon, were included. The extent of CAD was summarized in two ways, firstly as diseased (≥ 50% and ≥ 70% occlusion in at least one main coronary artery) versus non-diseased (entirely normal coronaries), and secondly, as CAD cumulative score based on Duke CAD Prognostic Index. A score of WP-years, capturing intensity and lifetime duration of exposure, was estimated for each individual. RESULTS: Lifetime exposure exceeding 40 WP-years was associated with a threefold significant increase in the odds of having severe stenosis (≥ 70%) compared to non-smokers (OR = 2.94, 95% CI 1.04-8.33) as well as with the CAD Index (β = 7.835, p-value = 0.027), net of the effect of socio-demographic characteristics, health behaviors and co-morbidity. A dose-response relationship between WP-years and percent stenosis was also established. WP smoking status (never, past and current) did not associate with CAD. CONCLUSIONS: Cumulative exposure to WP smoking is significantly associated with severe CAD. There is a need to monitor WP use among cardiac patients and include this information in their medical charts in the same manner cigarettes smoking is documented. This is likely to increase awareness of the hazards of WP smoking and prompt physicians to target WP tobacco control by providing advice to their patients on WP smoking cessation.
Authors: Wasim Maziak; Ziyad Ben Taleb; Mohammed Jawad; Rima Afifi; Rima Nakkash; Elie A Akl; Kenneth D Ward; Ramzi G Salloum; Tracey E Barnett; Brian A Primack; Scott Sherman; Caroline O Cobb; Erin L Sutfin; Thomas Eissenberg Journal: Tob Control Date: 2016-05-10 Impact factor: 7.552
Authors: Arash Etemadi; Hooman Khademi; Farin Kamangar; Neal D Freedman; Christian C Abnet; Paul Brennan; Reza Malekzadeh Journal: Tob Control Date: 2016-11-21 Impact factor: 7.552
Authors: Aruni Bhatnagar; Wasim Maziak; Thomas Eissenberg; Kenneth D Ward; George Thurston; Brian A King; Erin L Sutfin; Caroline O Cobb; Merlyn Griffiths; Larry B Goldstein; Mary Rezk-Hanna Journal: Circulation Date: 2019-05-07 Impact factor: 29.690